(Q35661046)

9 August 2017

1 reference

title

Human embryonic stem cells: a potential source for cellular therapy (English)

1 reference

human embryonic stem cell

9 August 2017

main subject

1 reference

1

Sharon Gerecht-Nir

0 references

author name string

Sharon Gerecht-Nir

series ordinal

1

1 reference

9 August 2017

Joseph Itskovitz-Eldor

series ordinal

2

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

American Journal of Transplantation

9 August 2017

published in

1 reference

9 August 2017

volume

4 Suppl 6

1 reference

9 August 2017

page(s)

51-57

1 reference

Prevention of cytomegalovirus disease in recipients of solid-organ transplants

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.00727.X

Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.00727.X

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.00727.X

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.00727.X

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.00727.X

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.00727.X

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.00727.X

Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.00727.X

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.00727.X

Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.00727.X

10.1111/J.1600-6135.2004.00727.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference